|TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes|
Hamburg, London, Lyon ... stops of interest for Lyonbiopole and its members in April 2018! Furthemore, the 7 French health competitiveness clusters have formed a network to speak with one voice.
The month of May will bring renewal for the cluster with the election of new representatives of colleges both Centers of Competence and SMEs at its General Assembly to be held on May 31 in Lyon. Lyonbiopole's team will be happy to meet you there.
Please do not forget to register as your presence is necessary for your association to keep supporting you daily.
|MedTech Expert Appointment a successful 2nd editionLyonbiopole co-organized together with MD101 Consulting and Axeme Recrutement Santé the “Rdv Experts Medtech”. This event took place in March in Lyon and gathered 60 participants. Pr. BERGER (neuro-oncologist, Grenoble University Hospital, co-founder of Medimprint) presented how a clinician could develop an innovative medical project from the idea to the incorporation of the start-up. Then, experts composing the panel: Mr. PIN (Lyon University Hospital), Mr. CHIGNON (Mérieux Développement), Mr. BARATIER (Resmed) and Mr. MASSARDIER (DTF Medical) were discussing about market access in the context of new EU regulation; how to promote innovation within hospitals; private funds for companies. This event was also a unique opportunity for SME’s to access free consultancy meeting with experts from MD101 Consulting.|
|The seven French health competitiveness clusters create a networkTo increase the visibility of their 1,300 members, including 1,000 SMEs, and to promote their economic value, the health clusters speak with one voice. The seven French health competitiveness clusters – Alsace Biovalley, Atlanpole Biotherapies, Cancer-Bio-Santé, Eurobiomed, Lyonbiopole, Medicen Paris Region […]|
|MAGIA CLUSTER VISITAs partner of the European project MAGIA dedicated to the creation of a Medtech Clusters Alliance, Lyonbiopole has participated in April in the second « cluster visit » of the project. This meeting organised at the German cluster « Life Science Nord » based in Hamburg, allow the partners to exchange on their internationalisation strategies and to meet SMEs members of the cluster in order to discuss their priorities and needs related to internationalisation. These discussions started in February at the first « cluster visit » in Lyon. They will continue in June in Torino at Biopmed’s and in September in Wallonia at Biowin’s premises.|
|Workshop on the Preclinical Development of ImmunotherapiesFor the 3rd consecutive year, Lyonbiopole and MabDesign have co-organized a day around immunotherapies to support innovation in this field. After “engineering of therapeutic antibodies” in 2016, the “routes of administration” in 2017, this 3rd edition was focused on the "preclinical development of immunotherapy". On April 24th 2018, this is thus more than 70 participants discussed on the needs at this stage of development encountered by companies developing immunotherapies and on specificities and predictivity of preclinical in vitro and in vivo models developed by French SMEs.|
|LYONBIOPOLE SUPPORTS ITS MEMBERS AT BIOTRINITYAs part of its International Development Plan funded by the Auvergne-Rhône-Alpes Region, Lyonbiopole supported 4 of its members: Veinsound, Osivax, Vetbiobank and Fab'entech on BioTrinity in London from April 23 to 25, 2018. They had the opportunity to present their projects to potential investors during pitch sessions or one-to-one meetings.|
|New membersAudensiel Healthcare, Lab of Excellence at the heart of innovation, supports healthcare professionals throughout the entire product development cycle: from clinical studies to industrialization. […]|
|New membersISARA is a school of reference in the Great South-East, located in Lyon and Avignon, recongnised at national and international levels in the fields of agriculture, food, rural development and the environment. [...]|
|Focus onELSALYS BIOTECH, a new player in immuno-oncology, member of Lyonbiopole, announces the registration of its Document de Base with the Autorité des Marchés Financiers (AMF).This is the first step in the proposed initial public offering of ELSALYS BIOTECH on the Paris Euronext Growth® market, subject to market conditions and the granting of its visa on the Prospectus for this operation. [...]|
|April 3th, 2018Biom'up and Athyrium close first tranche of bond financing for ¤ 25 million with stock warrants attached||April 5th, 2018LEUKOTAC® takes next step in paediatric acute steroidresistant GvHD||April 6th, 2018Antibiotic resistance: Nosopharm and the University of Illinois at Chicago collaborated|
|April 10th, 2018Adjuvatis launches its new website and presents its latest services in formulation and delivery of active ingredients||April 10th, 2018Synthelis & Sanofi Pasteur sign a partnership agreement||April 16th, 2018IXALTIS starts first clinical trial of Litoxetine in USA|
|April 20th, 2018Neolys Diagnostics has developed an automated immunofluorescence reader for its RadioProfile™ test||April 24th, 2018Biom'up has trained 200 surgeons|
|Pall Life Sciences|
May 5th, 2018Lyonbiopole General Assembly
May 31th, 2018Clinical Innovation Day 2018
June 19th, 2018
May 30th, 2018
June 25th, 2018
See All events
EUROPE & INTERNATIONAL
Before May 3th, 2018
Before May 16th, 2018
Before May 23th, 2018
Before June 5th, 2018
Before June 14th, 2018
Before September 13th, 2018
May 17th, 2018
May 25th, 2018
This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.